IGF1R and myeloid sarcoma: Moreover, research in MS models has revealed that exosomal let-7i miRNA can influence the disease’s pathogenesis by targeting the insulin-like growth factor 1 receptor (IGF1R)/TGF-β type 1 receptor (TGFBR1) signaling pathway, which underscores its therapeutic relevance [189].